Skip to content
Home/Companies/Healthcare/MedDay Pharmaceuticals
MP

MedDay Pharmaceuticals

Healthcare·France·Exited 2021·Held 5yr

MedDay Pharmaceuticals is a healthcare company, headquartered in France.

Entry
2016
Hold
5yr
Exit
2021
Est. EV
–

Who owns MedDay Pharmaceuticals?

MedDay Pharmaceuticals was owned by Andera Partners through BioDiscovery 4 (2013 vintage) from 2016 to 2021, exited via Trade Sale.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 4 · 2013 · VC

Key facts

HQFrance
SectorHealthcare
Exit Type
Trade Sale
Buyer
–
MOIC
–
Exit Year
2021

More from BioDiscovery 4

Other portfolio companies in the same fund.

Inotrem
Active
HealthcareFrance
Verona Pharma
Exited 2017
HealthcareUK· 2016
Autonomic Technologies
Exited 2020
HealthcareUS· 2015
to
GAMAMABS
Active
HealthcareFrance· 2015
ReViral
Exited 2022
HealthcareUK· 2015
to
Sanifit
Exited 2021
HealthcareSpain· 2015
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings